Skip to content

Project title: Comparing the Efficacy of Different Elonva (Corifollitropin Alfa) Protocols in Poor Responders undergoing IVF cycles: Follicular Phase Start vs. Luteal Phase Start, and the Double dose Elonva

Project title: Comparing the Efficacy of Different Elonva (Corifollitropin Alfa) Protocols in Poor Responders undergoing IVF cycles: Follicular Phase Start vs. Luteal Phase Start, and the Double dose Elonva

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241127063873N1
Enrollment
270
Registered
2025-08-31
Start date
2025-08-23
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian dysfunction. Ovarian dysfunction

Interventions

Intervention 1: Intervention group: Group A: Received corifollitropin alfa on the second day of the menstrual cycle (beginning of the follicular phase) and HMG injection (seven days after corifollitro

Sponsors

Avicenna research institute
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 42 Years

Inclusion criteria

Inclusion criteria: Diagnosis of poor ovarian response based on Bologna criteria. AMH level < 1.1 ng/ml or antral follicle count (AFC < 5) Body mass index 18 to 30 kg/m2 Willing to participate in the study

Exclusion criteria

Exclusion criteria: Uterine abnormalities Male-related infertility Underlying diseases that affect ovarian response or implantation.

Design outcomes

Primary

MeasureTime frame
En Number of mature oocytes. Timepoint: after Ooocyte Retrival. Method of measurement: observation.;Clinical pregnancy. Timepoint: after IVF. Method of measurement: Seeing the gestational sac.

Secondary

MeasureTime frame
Number of embryos. Timepoint: after IVF. Method of measurement: observation.;Biochemical pregnancy. Timepoint: After embryo transfer to the uterus. Method of measurement: Beta hcg blood level.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Soheila Arefi

Avicenna research institute

soheilaarefi@yahoo.com+98 21 4450 7734

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026